Gynecological Endocrinology · 2019 · 32 citations · 11 references
MedicineGynecologyObstetricsEmbryo TransferInfertilityReproductive MedicineFemale InfertilityIntracytoplasmic Sperm InjectionPregnancyAssisted Reproductive Technology ConceptionAssisted Reproductive Technology FailureControl Group DesignEmbryo Transfer Outcome AssessmentIntracytoplasmic Sperm Injection FertilizationLive Birth Outcome AssessmentPregnancy Outcome AssessmentPregnancy Rate Assessment
To evaluate the effect of empiric intralipid infusion therapy on pregnancy outcomes for patients with unexplained recurrent implantation failure (RIF) undergoing intracytoplasmic sperm injection (ICSI). A total of 142 patients with a history of unexplained RIF (3 or more cycles) were included in this randomized controlled trial. Patients were randomized into two groups, study group (n = 71) and control group (n = 71). The study group received intralipid 20% infusion on the day of embryo transfer (ET) and a second dose on the day of pregnancy test. The clinical pregnancy rate in the study group was 36.6% (n = 26) compared to 28.2% (n = 20) in the control group (OR 1.47, CI 0.72–2.98, p = .282). The live birth rate in the study group was 18.3% (n = 13) and 14.1% (n = 10) in the control group (OR 1.37, CI 0.55–3.36, p=.49). No side effects of intralipid therapy were reported in the study period. There was improvement in the pregnancy rate among women with unexplained RIF who received empiric intralipid infusion therapy; however, this improvement did not reach statistical significance.
11
World Collaborative Report on Assisted Reproductive Technology, 2002
J. de Mouzon, Paul Lancaster, K.G. Nygren et al. · Human Reproduction · 2009 · 186 citations · Full text
Medicine, Gynecology, Obstetrics +14
Andrew Sharkey · Reviews of Reproduction · 1998 · 165 citations · Full text
Trifon G. Lainas, Ioannis Sfontouris, Ioannis Z. Zorzovilis et al. · Human Reproduction · 2009 · 153 citations · Full text
Medicine, Endocrinology, Gynecology +16